Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunovant, Inc.

15.80
-0.0600-0.38%
Post-market: 15.800.00000.00%17:04 EDT
Volume:1.91M
Turnover:30.09M
Market Cap:2.70B
PE:-5.79
High:16.04
Open:16.04
Low:15.44
Close:15.86
Loading ...

Immunovant Price Target Maintained With a $51.00/Share by HC Wainwright & Co.

Dow Jones
·
08 Feb

Immunovant’s Strategic Positioning and Financial Strength Propel IMVT-1402 Towards Pivotal Studies

TIPRANKS
·
08 Feb

IMVT Q3 Loss Wider Than Expected, Stock Down, Pipeline in Focus

Zacks
·
07 Feb

Immunovant's Fiscal Q3 Loss Widens

MT Newswires Live
·
06 Feb

Immunovant Q3 2025 GAAP EPS $(0.76), Inline, Pro Forma Cash Balance Of Approximately $825M As Of December 31, 2024, Including Approximately $450M Gross Proceeds From A Private Placement

Benzinga
·
06 Feb

Immunovant Inc: as of December 31, 2024, Co's Cash and Cash Equivalents Totaled $374.7 Million

THOMSON REUTERS
·
06 Feb

BRIEF-Immunovant Q3 Net Income USD -111.122 Million

Reuters
·
06 Feb

Immunovant Q3 Basic EPS USD -0.76

THOMSON REUTERS
·
06 Feb

Immunovant Q3 Net Income USD -111.122 Million

THOMSON REUTERS
·
06 Feb

Press Release: Immunovant Reports Financial Results for the Quarter Ended December 31, 2024

Dow Jones
·
06 Feb

BRIEF-Immunovant Inc Selling Stockholders To Offer Up To 5.7 Million Shares Of Common Stock- SEC Filing

Reuters
·
25 Jan

Immunovant, Inc. (IMVT): The Biotech Stock with Biggest Upside Potential

Insider Monkey
·
18 Jan

Roivant Sciences buys Immunovant Inc. shares and repurchases its own stock for $336.9 million each

GuruFocus.com
·
16 Jan

Immunovant Is Maintained at Buy by B of A Securities

Dow Jones
·
15 Jan

Immunovant Inc : Bofa Global Research Cuts Price Objective to $45 From $48

THOMSON REUTERS
·
15 Jan

Analysts’ Top Healthcare Picks: Annexon Biosciences (ANNX), Immunovant (IMVT)

TIPRANKS
·
15 Jan

Immunovant Inc - to Sell 22.5 Mln Shares at $20 Each in Pipe

THOMSON REUTERS
·
13 Jan

Immunovant Announces $450 Million Private Placement

THOMSON REUTERS
·
13 Jan

Immunovant Announces $450 Million Private Placement

GlobeNewswire
·
13 Jan

Immunovant Cut to Peer Perform From Outperform by Wolfe Research

Dow Jones
·
03 Jan